ARTICLE | Management Tracks
Plus: Zaderej to retire as AxoGen CEO and updates from AxoGen, Delfi, Illumina, Evozyne, Kiyatec, Sosei, Twist, Novocure, Be Bio, Novo Holdings, Bioluminescence and more
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
January 6, 2024 2:40 AM UTC
Bo Jesper Hansen resigned as chairman of Swedish Orphan Biovitrum AB (SSE:SOBI) for health reasons. Hansen is succeeded by Annette Clancy, a 30-year veteran of GSK plc (LSE:GSK; NYSE:GSK) and Sobi board member since 2014.
Corteria Pharmaceuticals S.A.S., named Mark Pruzanski as chairman, succeeding Thierry Laugel, a managing partner at Kurma Partners, who will remain on the board. Pruzanski founded and was CEO of Intercept Pharmaceuticals Inc., then chairman and CEO of Versanis Bio Inc. until its acquisition by Eli Lilly and Co. (NYSE:LLY). Corteria is advancing a preclinical pipeline of heart failure therapies to treat different patient subsets. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651085/management-moves-abound-on-eve-of-jpm-including-new-chairs-for-sobi-corteria